SLN
Silence Therapeutics
SLN
SLN
29 hedge funds and large institutions have $102M invested in Silence Therapeutics in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
8% less capital invested
Capital invested by funds: $110M → $102M (-$8.45M)
Holders
29
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$6.57M | |
| 2 | +$1.2M | |
| 3 | +$731K | |
| 4 |
LOAME
Lombard Odier Asset Management (Europe)
London,
United Kingdom
|
+$671K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$526K |
Top Sellers
| 1 | -$2.52M | |
| 2 | -$1.45M | |
| 3 | -$1.38M | |
| 4 |
WM
WS Management
Jacksonville,
Florida
|
-$155K |
| 5 |
Morgan Stanley
New York
|
-$38.9K |